New indicators to evaluate bacteriological quality of the dialysis fluid and the associated inflammatory response in ESRD patients.
Krautzig
S
S
Department of Nephrology, Medizinische Hochschule Hannover, Germany.
Linnenweber
S
S
Schindler
R
R
Shaldon
S
S
Koch
K M
KM
Lonnemann
G
G
D015312:Hemodialysis Solutions / Q000592:standards*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008213:Lymphocyte Activation; D008567:Membranes, Artificial; D010539:Permeability; D011749:Pyrogens / Q000032:analysis* / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects*; D012795:Sialoglycoproteins / Q000032:analysis; D014871:Water Microbiology
D015312:Hemodialysis Solutions; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D008567:Membranes, Artificial; D011749:Pyrogens; D012795:Sialoglycoproteins